Comparative study of efficacy of minodronate, alendronate and risedronate in patients with osteoporosis

Comparative study of efficacy of minodronate, alendronate and risedronate in patients with osteoporosis - Comparison of efficacy of bisphosphonates in patients with osteoporosis

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000011407

Enrollment

150

Registered

2013-08-07

Start date

2011-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoporosis

Interventions

Minodronic acid Alendronate Risedronate

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Outpatients diagnosed with osteoporosis

Exclusion criteria

Exclusion criteria: 1. Patients with esophageal stricture or achalasia 2. Patients unable to remain upright for 30 min after dosing

Design outcomes

Primary

Measure	Time frame
Changes in bone mineral density	—

Secondary

Measure	Time frame
Changes in TRACP-5b and BAP Changes in low back pain Changes in IZUMO scale score	—

Countries

Japan

Contacts

Public ContactOsamu Nishiike

Kushiro-sanjikai Hospital Department of Orthopaedic Surgery

0154-41-1199

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026